Company Email Format Management

Aegros

Biotechnology Research Nsw, Au 65 employees

Employees: 65
Contacts: 3
Emails: 3
Phones: 1

aegros.com.au LinkedIn

Aegros Overview

Headquarters: Nsw, Au
Phone Number: Available in AeroLeads
Website: aegros.com.au
Industry: Biotechnology Research
Employees: 65
Founded: 2017
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Therapeutic plasma products and Building of therapeutic plasma facilities

About Aegros

At Aegros we believe access to life saving therapeutic plasma drugs is a human right and not a privilege. Our mission is to put the patient first through innovation and we do this thanks to our Australian invented Haemafrac®, Aegros' unique electroseparation process. Our TGA GMP-approved plasma fractionation plant in Macquarie Park, Sydney, manufactures a hyperimmune immunoglobulin product against Covid-19, made from convalescent plasma. Aegros is currently undertaking the final preparations for the submission of a dossier for the registration of this hyperimmune against Covid-19 on the Australian Register of Therapeutic Goods (ARTG) Simultaneously, Aegros is finishing the upgrade of its existing hyperimmune facility at Macquarie Park NSW to be able to process 100,000l of plasma per year.

Aegros Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Aegros Org Chart

Sample employees and titles

Name	Title	Location	Contact
Mike Swan	Chief Marketing Officer and Global Healthcare Commercial Leader.	Singapore	Email
Janet Bowen	Executive Director, Chief Quality and Regulatory Officer at Aegros Innovations at Aegros	Wichita, Kansas Metropolitan Area, United States	Email Phone
Dr. Ranjeet Ajmani	Plasma Fractionation and Blood Plasma Products		View
Damian Thornton	Redefining Plasma Fractionation Through Innovation	Macquarie Park, New South Wales, Australia	Email